Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria

Int J Tuberc Lung Dis. 2020 Sep 1;24(9):981-982. doi: 10.5588/ijtld.20.0418.
No abstract available

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / therapy
  • Humans
  • Nigeria
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / therapy
  • SARS-CoV-2
  • Tuberculosis / diagnosis
  • Tuberculosis / epidemiology
  • Tuberculosis / therapy*

Substances

  • Antitubercular Agents